NCT04740723View on ClinicalTrials.gov

Evaluation of the Integrated Radio Frequency Denervation System for the Treatment of Hypertension

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 6, 2021

Primary Completion Date

October 20, 2021

Study Completion Date

October 13, 2022

Conditions
HypertensionMetabolic Syndrome
Interventions
DEVICE

iRF System Renal Denervation

The iRF System is a percutaneous, catheter-based device which uses RF energy to circumferentially denervate the sympathetic nerves surrounding the artery

Trial Locations (2)

0112

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

0159

Tbilisi Heart and Vascular Clinic, Tbilisi

Sponsors

Lead Sponsor

Metavention
All Listed Sponsors
lead

Metavention

INDUSTRY

NCT04740723 - Evaluation of the Integrated Radio Frequency Denervation System for the Treatment of Hypertension | Biotech Hunter | Biotech Hunter